MYCN and neuroblastoma: As mentioned above, MYCN amplification is frequent in high-risk patients [28] and is utilized for patient-risk classification [34]; however, this is not the only mechanism responsible for the disease, since non-MYCN-amplified neuroblastoma is abundantly recorded in patients.